Skip to main content
Premium Trial:

Request an Annual Quote

Caliper, Shimadzu Settle Patent Litigation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today said that it had reached a settlement agreement with Shimadzu over a patent infringement suit it had filed against the Japanese firm two months ago.

Caliper had filed the suit in January in the US District Court for the Eastern District of Texas, alleging that Shimadzu's MCE-202 MultiNA instrument system, a microchip-based electrophoresis system that performs DNA and RNA size confirmation and quantitation, infringed 11 patents covering its LabChip technology.

According to Hopkinton, Mass.-based Caliper, Shimadzu denied infringing the patents, but it agreed to discontinue sales of the MultiNA system in the US. Further terms of the settlement agreement were not disclosed.